Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Biochemical Pharmacology|October 9, 1991
Reduced ouabain-sensitive potassium entry as a possible mechanism of multidrug-resistance in P388 cellsA Ramu, N Ramu, R GorodetskyCancer Treatment Reports|April 1, 1984
Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cellsA Ramu, D Glaubiger, H WeintraubJournal of Environmental Science & Engineering|March 12, 2011
Assessment of groundwater quality in Virudhunagar district (India): a statistical approachL Muthulakshmi, A Ramu, N KannanCancer Research|May 1, 1984
Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cellsA Ramu, L Cohen, D GlaubigerCancer Chemotherapy and Pharmacology|January 1, 1985
Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemiaA Ramu, M Fridkin, R SteinherzCancer Research|October 1, 1984
Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analoguesA Ramu, D Glaubiger, Z FuksProceedings of the National Academy of Sciences of the United States of America|April 1, 1983
Chemical evidence that catecholamines are transported across the chromaffin granule membrane as noncationic speciesA Ramu, M Levine, H PollardCancer Chemotherapy and Pharmacology|January 1, 1989
The cytotoxicity of T-2 toxin and related 12,13-epoxytrichothecenes to Adriamycin-sensitive and -resistant P388 leukemia cellsA Ramu, B Yagen, N RamuCancer Treatment Reports|October 1, 1983
Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cellsA Ramu, T C Shan, D GlaubigerMolecular Pharmacology|August 1, 1997
Quantitative structure-activity relationship of multidrug resistance reversal agentsG Klopman, L M Shi, A RamuPageof 5